Dentokind A tablets

Nchi: Armenia

Lugha: Kiingereza

Chanzo: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Viambatanisho vya kazi:

belladonna D6, chamomilla D6, ferrum phosphoricum D6, hepar sulfuris D12, pulsatilla D6

Inapatikana kutoka:

Dr. Gustav Klein GmbH & Co. KG

ATC kanuni:

առկա չէ

INN (Jina la Kimataifa):

belladonna D6, chamomilla D6, ferrum phosphoricum D6, hepar sulfuris D12, pulsatilla D6

Kipimo:

15mg+ 15mg+ 15mg+ 15mg+ 15mg

Dawa fomu:

tablets

Vitengo katika mfuko:

(150) in glass container

Dawa ya aina:

OTC

Idhini hali ya:

Registered

Idhini ya tarehe:

2021-02-12

Tabia za bidhaa

SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Dentokind A
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 tablet (100 mg) contains:
Active substances:
Belladonna trit. D6
15.00 mg
Chamomilla trit. D6
15.00 mg
Ferrum phosphoricum trit. D6
15.00 mg
Hepar sulfuris trit. D12
15.00 mg
Pulsatilla trit. D6
15.00 mg
Excipient with known effect: lactose monohydrate
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Teething symptoms such as irritability, restlessness, earaches,
painful gums, mild fever and softened
stools in infants and children.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Children under 1 year of age:
For acute complaints, 1 tablet is administered every hour, up to a
maximum of 6 tablets per day.
When the complaints improve, 1 tablet is administered 3 times per day.
Children aged 1 to 6 years:
For acute complaints, 2 tablets are administered every hour, up to a
maximum of 12 tablets per day.
When the complaints improve, 2 tablets are administered 3 times per
day.
Method of administration
Tablets should be allowed to dissolve slowly in the mouth. For small
children, tablets can be dissolved
in a little bit of water.
An interval of at least half an hour to meals should be kept.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substances or to any of the excipients
listed in section 6.1.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
This medicinal product contains lactose. Patients with rare hereditary
problems of galactose
intolerance, the Lapp lactase deficiency or glucose-galactose
malabsorption should not take this
medicinal product.
3
A reassessment of the therapy is necessary
- if the child is poorly responding to Dentokind A,
- if additional complaints arise.
4.5
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
Interactions with other medicinal products have not been observed. The
use of this homeopathic
medicinal product does not exclude the use of other medicinal